Patents by Inventor Stephen J. Kirchner

Stephen J. Kirchner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030159164
    Abstract: The invention generally relates to synthesis of essential fatty acids and their derivatives, long-chain polyunsaturated fatty acids (LC-PUFAs) and eicosanoids in transfected cells and in transgenic animals.
    Type: Application
    Filed: October 23, 2002
    Publication date: August 21, 2003
    Inventors: John Joseph Kopchick, Bruce Kelder, Yung-Sheng Huang, Stephen J. Kirchner, Pradip Mukerji
  • Patent number: 6403349
    Abstract: The subject invention relates to the identification of a gene involved in the elongation of polyunsaturated fatty acids (i.e., “elongase”) and to uses thereof. In particular, elongase is utilized in the conversion of gamma linolenic acid (GLA) to dihomogamma linolenic acid (DGLA) and in the conversion of 20:4n-3 to eicosapentaenoic acid (EPA). DGLA may be utilized in the production of polyunsaturated fatty acids, such as arachidonic acid (AA) which may be added to pharmaceutical compositions, nutritional compositions, animal feeds, as well as other products such as cosmetics.
    Type: Grant
    Filed: September 2, 1998
    Date of Patent: June 11, 2002
    Assignee: Abbott Laboratories
    Inventors: Pradip Mukerji, Amanda Eun-Yeong Leonard, Yung-Sheng Huang, Jennifer Thurmond, Stephen J. Kirchner
  • Patent number: 6146670
    Abstract: A nutritional formulation containing at least one of the following oligosaccharides: from about 400 to about 3500 mg/L of 3-fucosyllactose; from about 200 to about 2200 mg/L of lacto-N-fucopentaose III; from about 100 to about 1500 mg/L of lacto-N-fucopentaose II; from about 100 to about 2500 mg/L of difucosyllactose; from about 500 to about 4500 mg/L of 2' fucosyllactose; from about 250 to about 3300 mg/L of lacto-N-fucopentaose I; from about 100 to about 900 mg/L of Lacto-N-neoTetraose; from about 50 to about 2300 mg/L of lacto-N-fucopentaose V; or from about 300 to about 2800 mg/L of lacto-N-tetraose.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: November 14, 2000
    Assignee: Abbott Laboratories
    Inventors: Pedro A. Prieto, Stephen J. Kirchner, Renee M. Erney
  • Patent number: 6045854
    Abstract: A nutritional formulation containing at least one of the following oligosaccharides: from about 400 to about 3500 mg/L of 3-fucosyllactose; from about 200 to about 2200 mg/L of lacto-N-fucopentaose III; from about 100 to about 1500 mg/L of lacto-N-fucopentaose II; from about 100 to about 2500 mg/L of difucosyllactose; from about 500 to about 4500 mg/L of 2' fucosyllactose; from about 250 to about 3300 mg/L of lacto-N-fucopentaose I; from about 100 to about 900 mg/L of Lacto-N-neoTetraose; from about 50 to about 2300 mg/L of lacto-N-fucopentaose V; or from about 300 to about 2800 mg/L of lacto-N-tetraose.
    Type: Grant
    Filed: March 31, 1997
    Date of Patent: April 4, 2000
    Assignee: Abbott Laboraties
    Inventors: Pedro A. Prieto, Stephen J. Kirchner, Renee M. Erney
  • Patent number: 5039513
    Abstract: Disclosed are topical compositions comprising sorbohydroxamic acid with a radical scavenging compound which prevent damage to skin caused UV radiation. Also disclosed is a method for using these compositions topically, to prevent damage to skin caused by UV radiation exposure.
    Type: Grant
    Filed: August 25, 1989
    Date of Patent: August 13, 1991
    Assignee: The Procter & Gamble Company
    Inventors: Ranjit U. Chatterjee, Stephen J. Kirchner
  • Patent number: 4869897
    Abstract: Disclosed are pharmaceutical compositions comprising sorbohydroxamic acid, or pharmaceutically-acceptable salts thereof, which are useful for topical application to prevent damage to skin caused by acute or chronic UV exposure. Combinations of sorbohydroxamic acid together with tocopherol sorbate and/or sunscreens are also disclosed.Also disclosed is a method for using these compositions topically, prior to UV exposure, to prevent damage to skin caused by acute or chronic UV exposure.
    Type: Grant
    Filed: October 22, 1987
    Date of Patent: September 26, 1989
    Assignee: The Procter & Gamble Company
    Inventors: Ranjit Chatterjee, Stephen J. Kirchner